Public Profile

Santa Cruz Biotechnology Inc.

Santa Cruz Biotechnology Inc., often referred to as SCBT, is a leading provider of research tools and reagents, headquartered in the United States. Founded in 1991, the company has established itself as a key player in the biotechnology industry, specialising in the development of innovative products for life science research, including antibodies, proteins, and gene editing tools. With a strong presence in major operational regions across North America and Europe, Santa Cruz Biotechnology is renowned for its extensive catalogue of high-quality, validated reagents that support a wide range of applications in molecular biology and cell biology. The company’s commitment to scientific excellence and customer satisfaction has positioned it as a trusted partner for researchers worldwide, contributing to significant advancements in various fields, including cancer research and gene therapy.

DitchCarbon Score

How does Santa Cruz Biotechnology Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Santa Cruz Biotechnology Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Santa Cruz Biotechnology Inc.'s reported carbon emissions

Santa Cruz Biotechnology Inc., headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data and commitments, it is unclear how Santa Cruz Biotechnology Inc. is addressing climate change or its carbon footprint. The company may still be evaluating its strategies or developing initiatives to align with industry standards for sustainability and emissions reduction.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Santa Cruz Biotechnology Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Santa Cruz Biotechnology Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Santa Cruz Biotechnology Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Genovis AB (publ.)

SE
Health and social work services (85)
Updated 15 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers